Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Product-Page Research Positioning A product-page research guide should answer procurement questions without becoming a wellness article, treatment guide, or instruction page
A combination of L-citrulline (CIT) and Setria supplementation significantly increased NO levels in HUVECs
Compound Overview Class of Compound: Peptide Mechanism of Action: PT-141 is an agonist of the melanocortin receptors, with high affinity for MC4R, the stimulation of which increases sexual desire and causes sexual arousal in both men and women Notable Studies: Also Known As: Bremelanotide, bremelanotide acetate, Rekynda, Vyleesi, CID9941379 Research Applications: Sexual funtion Male sexual arousal Anti-inflammatory action Risks: Injection-related side effects Temporarily increases blood pressure Not FDA approved to treat men
10.1016/j.phrs.2020.104947 Pharmacol
US$ 25.09
US$ 27.94
US$ 22.19
US$ 29.73
